Citations (132)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Deirdre Cronin-Fenton, Timothy L. Lash, Thomas P. Ahern, Per Damkier, Peer Christiansen, Bent Ejlertsen & Henrik T. Sørensen. (2018) Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database. Acta Oncologica 57:1, pages 120-128.
Read now
Read now
Renae D Van Wyhe, Omar M Rahal & Wendy A Woodward. (2017) Effect of statins on breast cancer recurrence and mortality: a review. Breast Cancer: Targets and Therapy 9, pages 559-565.
Read now
Read now
Minas Sakellakis, Karolina Akinosoglou, Anastasia Kostaki, Despina Spyropoulou & Angelos Koutras. (2016) Statins and risk of breast cancer recurrence. Breast Cancer: Targets and Therapy 8, pages 199-205.
Read now
Read now
Jessica Barochiner, Lucas S Aparicio & Gabriel D Waisman. (2014) Challenges associated with peripheral arterial disease in women. Vascular Health and Risk Management 10, pages 115-128.
Read now
Read now
Jennifer W Wu, Denise M Boudreau, Yikyung Park, Naoko I Simonds & Andrew N Freedman. (2014) Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature. Expert Opinion on Drug Safety 13:8, pages 1071-1099.
Read now
Read now
Stefanos Bonovas, Theodore Lytras & Nikolaos M Sitaras. (2014) Statin use and breast cancer: do we need more evidence and what should this be?. Expert Opinion on Drug Safety 13:3, pages 271-275.
Read now
Read now
Articles from other publishers (126)
Hui-Jeong Hwang & Taek-Gu Lee. (2023) Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea. PLOS ONE 18:11, pages e0294649.
Crossref
Crossref
L. Lukas Löfling, Nathalie C. Støer, Bettina Kulle Andreassen, Giske Ursin & Edoardo Botteri. (2023) Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study. Breast Cancer Research 25:1.
Crossref
Crossref
Vikash Jaiswal, Vibhor Agrawal, Song Peng Ang, Marina Saleeb, Angela Ishak, Maha Hameed, Kripa Rajak, Kriti Kalra & Akash Jaiswal. (2023) Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy.
Crossref
Crossref
Mohamad Ali Hijazi, André Gessner & Nahed El-Najjar. (2023) Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp. Cancers 15:12, pages 3199.
Crossref
Crossref
Hajir Ali Hussein & Firas Shawqi Algburi. (2023) The role of Renin angiotensin aldosterone system in women with breast cancer before and after treatment. Bionatura 8:2, pages 1-9.
Crossref
Crossref
Yung-Lung Chang, Chung-Hsing Chou, Yao-Feng Li, Li-Chun Huang, Ying Kao, Dueng-Yuan Hueng & Chia-Kuang Tsai. (2023) Antiproliferative and apoptotic effects of telmisartan in human glioma cells. Cancer Cell International 23:1.
Crossref
Crossref
Oliver William Scott, Sandar TinTin, Sixten Harborg, Marion J. J. Kuper-Hommel, Ross Lawrenson & J. Mark Elwood. (2023) Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study. Breast Cancer Research and Treatment 199:1, pages 195-206.
Crossref
Crossref
Erwin Danil Yulian, Nurjati Chairani Siregar, Bajuadji Sudijono & Lie Rebecca Yen Hwei. (2023) The role of HMGCR expression in combination therapy of simvastatin and FAC treated locally advanced breast cancer patients. Breast Disease 42:1, pages 73-83.
Crossref
Crossref
Koji Takada, Shinichiro Kashiwagi, Nozomi Iimori, Rika Kouhashi, Akimichi Yabumoto, Wataru Goto, Yuka Asano, Yukie Tauchi, Tamami Morisaki, Kana Ogisawa, Masatsune Shibutani, Hiroaki Tanaka & Kiyoshi Maeda. (2023) Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer. BMC Cancer 23:1.
Crossref
Crossref
Sabrina P. Koh, Ethan J. Kilmister, Agadha C. Wickremesekera, Matthew J. Munro, Clint Gray & Swee T. Tan. 2023. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases
277
339
.
Luka Peric, Sonja Vukadin, Ana Petrovic, Lucija Kuna, Nora Puseljic, Renata Sikora, Karla Rozac, Aleksandar Vcev & Martina Smolic. (2022) Glycosylation Alterations in Cancer Cells, Prognostic Value of Glycan Biomarkers and Their Potential as Novel Therapeutic Targets in Breast Cancer. Biomedicines 10:12, pages 3265.
Crossref
Crossref
Ethan J. Kilmister, Sabrina P. Koh, Freya R. Weth, Clint Gray & Swee T. Tan. (2022) Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment. Biomedicines 10:11, pages 2988.
Crossref
Crossref
Jenna E. van Leeuwen, Wail Ba-Alawi, Emily Branchard, Jennifer Cruickshank, Wiebke Schormann, Joseph Longo, Jennifer Silvester, Peter L. Gross, David W. Andrews, David W. Cescon, Benjamin Haibe-Kains, Linda Z. Penn & Deena M. A. Gendoo. (2022) Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins. Nature Communications 13:1.
Crossref
Crossref
Brian M. Egan, Andrea Scharf, Franziska Pohl & Kerry Kornfeld. (2022) Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals. Frontiers in Pharmacology 13.
Crossref
Crossref
A Pickler, G Mendes, T Tanure, L Serqueira, G Sena, G Fidalgo, M Colaço, E Muñoz, S Ferreira-Machado, C C Lau, C Salata, A Mantuano, C L Mota, A Nascimento, C E de Almeida & R C Barroso. (2022) Elemental changes in heart and coronaries after breast cancer radiotherapy assessed by synchrotron radiation soft X-ray spectromicroscopy. Journal of Physics: Conference Series 2340:1, pages 012001.
Crossref
Crossref
Andy Göbel, Romy M. Riffel, Lorenz C. Hofbauer & Tilman D. Rachner. (2022) The mevalonate pathway in breast cancer biology. Cancer Letters 542, pages 215761.
Crossref
Crossref
Leah L. Zullig, Anthony D. Sung, Michel G. Khouri, Shelley Jazowski, Nishant P. Shah, Andrea Sitlinger, Dan V. Blalock, Colette Whitney, Robin Kikuchi, Hayden B. Bosworth, Matthew J. Crowley, Karen M. Goldstein, Igor Klem, Kevin C. Oeffinger & Susan Dent. (2022) Cardiometabolic Comorbidities in Cancer Survivors. JACC: CardioOncology 4:2, pages 149-165.
Crossref
Crossref
Peng Chen, Cheng Zhong, Shengxi Jin, Yiyin Zhang, Yirun Li, Qiming Xia, Jiaxi Cheng, Xiaoxiao Fan & Hui Lin. (2022) Global Trends in Research of Lipid Metabolism in T lymphocytes From 1985 to 2022: A Bibliometric Analysis. Frontiers in Immunology 13.
Crossref
Crossref
Roberto Valente, Stefano Crippa, Urban Arnelo, Giuseppe Vanella, Giulia Zerboni, Laura Zarantonello, Alessandro Fogliati, Paolo Giorgio Arcidiacono, Miroslav Vujasinovic, Johannes Matthias Lohr, Massimo Falconi, Gabriele Capurso & Marco Del Chiaro. (2022) The use of ace inhibitors influences the risk of progression of BD-IPMNs under follow-up. Pancreatology 22:4, pages 516-524.
Crossref
Crossref
Yirong Sim, Cindy Lim, Nitar Phyu, Kiat Tee Benita Tan, Lita Sui Tjien Chew, Chow Yin Wong, Preetha Madhukumar, Wei Sean Yong, Sue Zann Lim, Julie Liana Bte Hamzah, Si Ying Tan, Wen Yee Chay, Fuh Yong Wong, Puay Hoon Tan & Veronique Kiak-Mien Tan. (2022) The Impact of Statin Use and Breast Cancer Recurrence - A Retrospective Study in Singapore. Frontiers in Oncology 12.
Crossref
Crossref
Maria Inasu, Maria Feldt, Helena Jernström, Signe Borgquist & Sixten Harborg. (2022) Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study. The Breast 61, pages 123-128.
Crossref
Crossref
Guodong Zhao, Yanjun Ji, Qing Ye, Xin Ye, Guanqun Wo, Xi Chen, Xinyi Shao & Jinhai Tang. (2021) Effect of statins use on risk and prognosis of breast cancer: a meta-analysis. Anti-Cancer Drugs 33:1, pages e507-e518.
Crossref
Crossref
Nicole C. Lorona, Linda S. Cook, Mei-Tzu C. Tang, Deirdre A. Hill, Charles L. Wiggins & Christopher I. Li. (2021) Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer. Cancer Causes & Control 32:12, pages 1375-1384.
Crossref
Crossref
Juan Luis Gomez Marti, Colin H. Beckwitt, Amanda M. Clark & Alan Wells. (2021) Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer. British Journal of Cancer 125:9, pages 1285-1298.
Crossref
Crossref
Giovanna Revilla, Lídia Cedó, Mireia Tondo, Antonio Moral, José Ignacio Pérez, Rosa Corcoy, Enrique Lerma, Victoria Fuste, Srivinasa T. Reddy, Francisco Blanco-Vaca, Eugènia Mato & Joan Carles Escolà-Gil. (2021) LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies. Seminars in Cancer Biology 73, pages 134-157.
Crossref
Crossref
Aida Raigon Ponferrada, Jose Luis Guerrero Orriach, Juan Carlos Molina Ruiz, Salvador Romero Molina, Aurelio Gómez Luque & Jose Cruz Mañas. (2021) Breast Cancer and Anaesthesia: Genetic Influence. International Journal of Molecular Sciences 22:14, pages 7653.
Crossref
Crossref
Noha M. Mounier, Sara A. Wahdan, Amany M. Gad & Samar S. Azab. (2021) Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 394:7, pages 1537-1551.
Crossref
Crossref
Rosemary Yu, Joseph Longo, Jenna E. van Leeuwen, Cunjie Zhang, Emily Branchard, Mohamad Elbaz, David W. Cescon, Richard R. Drake, James W. Dennis & Linda Z. Penn. (2021)
Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced
N
-glycosylation Abundance and Branching
. Cancer Research 81:10, pages 2625-2635.
Crossref
Crossref
Yu‐Tsai Lin, Hung‐Chen Wang, Ming‐Hsien Tsai, Yan‐Ye Su, Ming‐Yu Yang & Chih‐Yen Chien. (2021) Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma. Cancer 127:10, pages 1606-1619.
Crossref
Crossref
Flávia Sardela de Miranda, João Pedro Tôrres Guimarães, Kalhara R. Menikdiwela, Brennan Mabry, Rabin Dhakal, Rakhshanda layeequr Rahman, Hanna Moussa & Naima Moustaid-Moussa. (2021) Breast cancer and the renin-angiotensin system (RAS): Therapeutic approaches and related metabolic diseases. Molecular and Cellular Endocrinology 528, pages 111245.
Crossref
Crossref
Jia‐Li Feng & Xiwen Qin. (2020) Does adherence to lipid‐lowering medications improve cancer survival? A nationwide study of breast and colorectal cancer, and melanoma. British Journal of Clinical Pharmacology 87:4, pages 1847-1858.
Crossref
Crossref
Nalinie Joharatnam-Hogan, Leo Alexandre, James Yarmolinsky, Blossom Lake, Nigel Capps, Richard M Martin, Alistair Ring, Fay Cafferty & Ruth E Langley. (2021) Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs. Current Oncology Reports 23:3.
Crossref
Crossref
Litian Yin, Zhongmei He, Bing Yi, Linyuan Xue & Jianxin Sun. (2020) Simvastatin Suppresses Human Breast Cancer Cell Invasion by Decreasing the Expression of Pituitary Tumor-Transforming Gene 1. Frontiers in Pharmacology 11.
Crossref
Crossref
Eerik E.E. Santala, Mika O. Murto, Miia Artama, Eero Pukkala, Kala Visvanathan & Teemu J. Murtola. (2020) Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival—A Nationwide Cohort Study from Finland. Cancer Epidemiology, Biomarkers & Prevention 29:11, pages 2376-2382.
Crossref
Crossref
Hui Lv, Ding Shi, Min Fei, Yu Chen, Fei Xie, Zhuoyan Wang, Ying Wang & Peiying Hu. (2020) Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies. Frontiers in Oncology 10.
Crossref
Crossref
Fabian Bernhard Pallasch & Udo Schumacher. (2020) Angiotensin Inhibition, TGF-β and EMT in Cancer. Cancers 12:10, pages 2785.
Crossref
Crossref
Fahmida Rasha, Latha Ramalingam, Kalhara Menikdiwela, Arelys Hernandez, Hanna Moussa, Lauren Gollahon, Rakhshanda Layeequr Rahman & Naima Moustaid-Moussa. (2020) Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions. Experimental Cell Research 394:1, pages 112114.
Crossref
Crossref
Sixten Harborg, Uffe Heide-Jørgensen, Thomas P. Ahern, Marianne Ewertz, Deirdre Cronin-Fenton & Signe Borgquist. (2020) Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study. Breast Cancer Research and Treatment 183:1, pages 153-160.
Crossref
Crossref
Marcos V. Perini, Rhynelle S. Dmello, Tracy L. Nero & Ashwini L. Chand. (2020) Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments. Pharmacology & Therapeutics 211, pages 107527.
Crossref
Crossref
Jing Yang, Chunyu Li, Ying Shen, Hong Zhou, Yueqin Shao, Wei Zhu & Yan Chen. (2020) Impact of statin use on cancer-specific mortality and recurrence. Medicine 99:14, pages e19596.
Crossref
Crossref
Barbara A. Cohn, Michele A. La Merrill, Nickilou Y. Krigbaum, Miaomiao Wang, June-Soo Park, Myrto Petreas, Gregory Yeh, Russell C. Hovey, Lauren Zimmermann & Piera M. Cirillo. (2020) In utero exposure to poly− and perfluoroalkyl substances (PFASs) and subsequent breast cancer. Reproductive Toxicology 92, pages 112-119.
Crossref
Crossref
Grace H. McGregor, Andrew D. Campbell, Sigrid K. Fey, Sergey Tumanov, David Sumpton, Giovanny Rodriguez Blanco, Gillian Mackay, Colin Nixon, Alexei Vazquez, Owen J. Sansom & Jurre J. Kamphorst. (2020) Targeting the Metabolic Response to Statin-Mediated Oxidative Stress Produces a Synergistic Antitumor Response. Cancer Research 80:2, pages 175-188.
Crossref
Crossref
Signe Borgquist, Per Broberg, Jasaman Tojjar & Håkan Olsson. (2019) Statin use and breast cancer survival – a Swedish nationwide study. BMC Cancer 19:1.
Crossref
Crossref
Stephanie S. Faubion, Ekta Kapoor, Ann M. Moyer, Howard N. Hodis & Virginia M. Miller. (2019) Statin therapy: does sex matter?. Menopause 26:12, pages 1425-1435.
Crossref
Crossref
Anouk J. Rombouts, Niek Hugen, Rob H. Verhoeven, Josephina G. Kuiper, Philip M. Poortmans, Johannes H. de Wilt & Iris D. Nagtegaal. (2019) Is preoperative chemoradiation in rectal cancer patients modulated by ACE inhibitors? Results from the Dutch Cancer Registry. Radiotherapy and Oncology 138, pages 86-92.
Crossref
Crossref
Xingzhe Ma, Enguang Bi, Yong Lu, Pan Su, Chunjian Huang, Lintao Liu, Qiang Wang, Maojie Yang, Matthew F. Kalady, Jianfei Qian, Aijun Zhang, Anisha A. Gupte, Dale J. Hamilton, Chengyun Zheng & Qing Yi. (2019) Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. Cell Metabolism 30:1, pages 143-156.e5.
Crossref
Crossref
Yong Sun Lee, In Jun Yeo, Ki Cheon Kim, Sang-Bae Han & Jin Tae Hong. (2019) Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity. Frontiers in Immunology 10.
Crossref
Crossref
Lídia Cedó, Srinivasa T. Reddy, Eugènia Mato, Francisco Blanco-Vaca & Joan Carles Escolà-Gil. (2019) HDL and LDL: Potential New Players in Breast Cancer Development. Journal of Clinical Medicine 8:6, pages 853.
Crossref
Crossref
Daniel P. Regan, Jonathan W. Coy, Kirti Kandhwal Chahal, Lyndah Chow, Jade N. Kurihara, Amanda M. Guth, Irina Kufareva & Steven W. Dow. (2019) The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment. The Journal of Immunology 202:10, pages 3087-3102.
Crossref
Crossref
Denise M. Boudreau, Lu Chen, Onchee Yu, Erin J. Aiello Bowles & Jessica Chubak. (2019) Risk of second breast cancer events with chronic opioid use in breast cancer survivors. Pharmacoepidemiology and Drug Safety 28:5, pages 740-753.
Crossref
Crossref
Helga Tryggvadottir, Louise Huzell, Emma Gustbée, Maria Simonsson, Andrea Markkula, Karin Jirström, Carsten Rose, Christian Ingvar, Signe Borgquist & Helena Jernström. (2018) Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients. Frontiers in Oncology 8.
Crossref
Crossref
Maliha T. Munir, Christopher Ponce, Catherine A. Powell, Kaiser Tarafdar, Teruyoshi Yanagita, Mahua Choudhury, Lauren S. Gollahon & Shaikh M. Rahman. (2018) The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 183, pages 1-9.
Crossref
Crossref
Amanda Leiter, Nina A. Bickell, Derek LeRoith, Anupma Nayak, Sheldon M. Feldman, Neil B. Friedman, Alison Estabrook, Tari A. King, Kezhen Fei, Rebeca Franco & Emily J. Gallagher. (2017) Statin Use and Breast Cancer Prognosis in Black and White Women. Hormones and Cancer 9:1, pages 55-61.
Crossref
Crossref
Isobel Okoye, Afshin Namdar, Lai Xu, Nicole Crux & Shokrollah Elahi. (2017) Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling. Oncotarget 8:58, pages 98215-98232.
Crossref
Crossref
Matthias Pinter, Arndt Weinmann, Marcus-Alexander Wörns, Florian Hucke, Simona Bota, Jens U Marquardt, Dan G Duda, Rakesh K Jain, Peter R Galle, Michael Trauner, Markus Peck-Radosavljevic & Wolfgang Sieghart. (2017) Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma. United European Gastroenterology Journal 5:7, pages 987-996.
Crossref
Crossref
Matthias Pinter & Rakesh K. Jain. (2017) Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. Science Translational Medicine 9:410.
Crossref
Crossref
Amelia Smith, Laura Murphy, Lina Zgaga, Thomas I Barron & Kathleen Bennett. (2017) Pre-diagnostic statin use, lymph node status and mortality in women with stages I–III breast cancer. British Journal of Cancer 117:4, pages 588-596.
Crossref
Crossref
Siker Kimbung, Ching-yi Chang, Pär-Ola Bendahl, Laura Dubois, J Will Thompson, Donald P McDonnell & Signe Borgquist. (2017) Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer. Endocrine-Related Cancer 24:7, pages 319-329.
Crossref
Crossref
Binliang Liu, Zongbi Yi, Xiuwen Guan, Yi-Xin Zeng & Fei Ma. (2017) The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis. Breast Cancer Research and Treatment 164:1, pages 1-11.
Crossref
Crossref
Amee J. George, Andrew Allen & Ashwini L. Chand. (2017) Repurposing ARBs as treatments for breast cancer. Aging 9:5, pages 1357-1358.
Crossref
Crossref
Yunseo Woo & Yu-Jin Jung. (2017) Angiotensin II receptor blockers induce autophagy in prostate cancer cells. Oncology Letters 13:5, pages 3579-3585.
Crossref
Crossref
Amelia Smith, Laura Murphy, Kathleen Bennett & Thomas I Barron. (2017) Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life. Supportive Care in Cancer 25:5, pages 1629-1637.
Crossref
Crossref
Heidi S. Wirtz, Gregory S. Calip, Diana S. M. Buist, Julie R. Gralow, William E. Barlow, Shelly Gray & Denise M. Boudreau. (2017) Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. American Journal of Epidemiology 185:8, pages 661-672.
Crossref
Crossref
Rhiannon Coulson, Seng H. Liew, Angela A. Connelly, Nicholas S. Yee, Siddhartha Deb, Beena Kumar, Ana C. Vargas, Sandra A. O’Toole, Adam C. Parslow, Ashleigh Poh, Tracy Putoczki, Riley J. Morrow, Mariah Alorro, Kyren A. Lazarus, Evie F.W. Yeap, Kelly L. Walton, Craig A. Harrison, Natalie J. Hannan, Amee J. George, Colin D. Clyne, Matthias Ernst, Andrew M. Allen & Ashwini L. Chand. (2017) The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma. Oncotarget 8:12, pages 18640-18656.
Crossref
Crossref
Hong Sun, Tao Li, Rongyuan Zhuang, Weimin Cai & Yuanting Zheng. (2017) Do renin–angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?. Medicine 96:13, pages e6394.
Crossref
Crossref
Zubing Mei, Mining Liang, Lezhi Li, Yi Zhang, Qingming Wang & Wei Yang. (2017) Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals. International Journal of Cancer 140:5, pages 1068-1081.
Crossref
Crossref
Taejong Song, Chel Hun Choi, Mi Kyoung Kim, Mi-La Kim, Bo Seong Yun & Seok Ju Seong. (2017) The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis. European Journal of Cancer Prevention 26:1, pages 78-85.
Crossref
Crossref
Úna C. Mc Menamin, Liam J. Murray, Carmel M. Hughes & Chris R. Cardwell. (2016) Statin use and breast cancer survival: a nationwide cohort study in Scotland. BMC Cancer 16:1.
Crossref
Crossref
Stephen R. Spindler, Patricia L. Mote & James M. Flegal. (2016) Combined statin and angiotensin-converting enzyme (ACE) inhibitor treatment increases the lifespan of long-lived F1 male mice. AGE 38:5-6, pages 379-391.
Crossref
Crossref
Peter J. Mullen, Rosemary Yu, Joseph Longo, Michael C. Archer & Linda Z. Penn. (2016) The interplay between cell signalling and the mevalonate pathway in cancer. Nature Reviews Cancer 16:11, pages 718-731.
Crossref
Crossref
Sashidhar Manthravadi, Anuj Shrestha & Sheshadri Madhusudhana. (2016) Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis. International Journal of Cancer 139:6, pages 1281-1288.
Crossref
Crossref
Siker Kimbung, Barbara Lettiero, Maria Feldt, Ana Bosch & Signe Borgquist. (2016) High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer. Oncotarget 7:37, pages 59640-59651.
Crossref
Crossref
Amelia Smith, Laura Murphy, Linda Sharp, Darran O'Connor, William M Gallagher, Kathleen Bennett & Thomas I Barron. (2016) De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I–III breast cancer. British Journal of Cancer 115:5, pages 592-598.
Crossref
Crossref
Jian Shen, Yan-Mei Huang, Min Wang, Xue-Zhi Hong, Xin-Nan Song, Xia Zou, Yan-Hong Pan, Wei Ling, Min-Hui Zhu, Xiao-Xi Zhang, Yi Sui & Hai-Lu Zhao. (2016) Renin–angiotensin system blockade for the risk of cancer and death. Journal of the Renin-Angiotensin-Aldosterone System 17:3, pages 147032031665667.
Crossref
Crossref
Deirdre P. Cronin-Fenton, Uffe Heide-Jørgensen, Thomas P. Ahern, Timothy L. Lash, Peer Christiansen, Bent Ejlertsen & Henrik T. Sørensen. (2016) Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence. Epidemiology 27:4, pages 586-593.
Crossref
Crossref
Banu K. Arun, Yun Gong, Diane Liu, Jennifer K. Litton, Angelica M. Gutierrez-Barrera, J. Jack Lee, Lana Vornik, Nuhad K. Ibrahim, Terri Cornelison, Gabriel N. Hortobagyi, Brandy M. Heckman-Stoddard, Kimberly B. Koenig, Ricardo R. Alvarez, James L. Murray, Vicente Valero, Scott M. Lippman, Powel Brown & Nour Sneige. (2016) Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer. Breast Cancer Research and Treatment 158:1, pages 67-77.
Crossref
Crossref
Sara Raimondi, Edoardo Botteri, Elisabetta Munzone, Carlo Cipolla, Nicole Rotmensz, Andrea DeCensi & Sara Gandini. (2016) Use of beta‐blockers, angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta‐analysis. International Journal of Cancer 139:1, pages 212-219.
Crossref
Crossref
Sohun Moonindranath & Huiling Shen. (2016) Statins and Breast Cancer: An Overview of the Current Situation. Advances in Breast Cancer Research 05:01, pages 14-29.
Crossref
Crossref
Hadar Goldvaser, Shulamit Rizel, Daniel Hendler, Victoria Neiman, Daniel Shepshelovich, Tzippy Shochat, Aaron Sulkes, Baruch Brenner & Rinat Yerushalmi. (2016) The Association between Angiotensin Receptor Blocker Usage and Breast Cancer Characteristics. Oncology 91:4, pages 217-223.
Crossref
Crossref
Hadar Goldvaser, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Daniel Shepshelovich, Tzippy Shochat, Aaron Sulkes, Baruch Brenner & Rinat Yerushalmi. (2016) The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics. International Journal of Endocrinology 2016, pages 1-9.
Crossref
Crossref
Mark A. MoyadMark A. Moyad. 2016. Integrative Medicine for Breast Cancer. Integrative Medicine for Breast Cancer
141
171
.
Qi-Jun Wu, Chao Tu, Yuan-Yuan Li, Jingjing Zhu, Ke-Qing Qian, Wen-Jing Li & Lang Wu. (2015) Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget 6:40, pages 42988-43004.
Crossref
Crossref
Anne Blaes, Daniel Duprez, Todd Defor, Ryan Shanley, Heather Beckwith, Tufia Haddad, David Potter, Douglas Yee, Kinjal Sanghavi & Pamala Jacobson. (2015) Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment. SpringerPlus 4:1.
Crossref
Crossref
Oscar Arrieta, Cynthia Villarreal-Garza, Gloria Vizcaíno, Benjamín Pineda, Norma Hernández-Pedro, Patricia Guevara-Salazar, Talia Wegman-Ostrosky, Geraldine Villanueva-Rodríguez & Armando Gamboa-Domínguez. (2015) Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer. Tumor Biology 36:7, pages 5627-5634.
Crossref
Crossref
Shanliang Zhong, Xiaohui Zhang, Lin Chen, Tengfei Ma, Jinhai Tang & Jianhua Zhao. (2015) Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies. Cancer Treatment Reviews 41:6, pages 554-567.
Crossref
Crossref
Pinkal Desai, Amy Lehman, Rowan T. Chlebowski, Marilyn L. Kwan, Monica Arun, JoAnn E. Manson, Sayeh Lavasani, Sylvia Wasswertheil-Smoller, Gloria E. Sarto, Meryl LeBoff, Jane Cauley, Michele Cote, Jennifer Beebe-Dimmer, Allison Jay & Michael S. Simon. (2015) Statins and breast cancer stage and mortality in the Women’s Health Initiative. Cancer Causes & Control 26:4, pages 529-539.
Crossref
Crossref
Hongmei Wang, Zhongxing Liao, Yan Zhuang, Ying Liu, Lawrence B. Levy, Ting Xu, Syed Wamique Yusuf & Daniel R. Gomez. (2015) Incidental Receipt of Cardiac Medications and Survival Outcomes Among Patients With Stage III Non–Small-Cell Lung Cancer After Definitive Radiotherapy. Clinical Lung Cancer 16:2, pages 128-136.
Crossref
Crossref
Sylvie Rodrigues-Ferreira & Clara Nahmias. (2015) G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?. Frontiers in Pharmacology 6.
Crossref
Crossref
Chris R. Cardwell, Blanaid M. Hicks, Carmel Hughes & Liam J. Murray. (2015) Statin Use After Diagnosis of Breast Cancer and Survival. Epidemiology 26:1, pages 68-78.
Crossref
Crossref
Chris R Cardwell, Úna C Mc Menamin, Blánaid M Hicks, Carmel Hughes, Marie M Cantwell & Liam J Murray. (2014) Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts. BMC Medicine 12:1.
Crossref
Crossref
Teemu J. Murtola, Kala Visvanathan, Miia Artama, Harri Vainio & Eero Pukkala. (2014) Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland. PLoS ONE 9:10, pages e110231.
Crossref
Crossref
Simona Pisanti, Paola Picardi, Elena Ciaglia, Alba D’Alessandro & Maurizio Bifulco. (2014) Novel prospects of statins as therapeutic agents in cancer. Pharmacological Research 88, pages 84-98.
Crossref
Crossref
Stefanos Bonovas. (2014) Statins: Do They Have a Potential Role in Cancer Prevention and Modifying Cancer-Related Outcomes?. Drugs 74:16, pages 1841-1848.
Crossref
Crossref
Thomas P Ahern, Timothy L Lash, Per Damkier, Peer M Christiansen & Deirdre P Cronin-Fenton. (2014) Statins and breast cancer prognosis: evidence and opportunities. The Lancet Oncology 15:10, pages e461-e468.
Crossref
Crossref
Kristine Pelton, Christine M. Coticchia, Adam S. Curatolo, Carl P. Schaffner, David Zurakowski, Keith R. Solomon & Marsha A. Moses. (2014) Hypercholesterolemia Induces Angiogenesis and Accelerates Growth of Breast Tumors in Vivo. The American Journal of Pathology 184:7, pages 2099-2110.
Crossref
Crossref
Ronald M. Witteles & Akanksha Thakur. (2014) Reply to “Heart Failure and Breast Cancer: Emerging Controversies Regarding Some Cardioprotective Strategies”. Journal of Cardiac Failure 20:6, pages 457.
Crossref
Crossref
Alberto Milan, Elisabetta Puglisi, Laura Ferrari, Giulia Bruno, Isabel Losano & Franco Veglio. (2014) Arterial hypertension and cancer. International Journal of Cancer 134:10, pages 2269-2277.
Crossref
Crossref
Denise M. Boudreau, Onchee Yu, Jessica Chubak, Heidi S. Wirtz, Erin J. Aiello Bowles, Monica Fujii & Diana S. M. Buist. (2014) Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Research and Treatment 144:2, pages 405-416.
Crossref
Crossref
Matthaeus Stoehr, Christian Mozet, Andreas Boehm, Achim Aigner, Andreas Dietz & Gunnar Wichmann. (2014) Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics. Cancer Chemotherapy and Pharmacology 73:4, pages 827-837.
Crossref
Crossref
G. Verhoest, T. Dolley-Hitze, F. Jouan, K. Bensalah, Y. Arlot-Bonnemains, F. Dugay, M.-A. Belaud-Rotureau, N. Rioux-Leclercq & C. Vigneau. (2014) Système rénine-angiotensine et cancers urologiques. Progrès en Urologie 24:2, pages 73-79.
Crossref
Crossref
Mehmet Ali Nahit Şendur, Sercan Aksoy, Ozan Yazıcı, Nuriye Y. Ozdemir, Nurullah Zengin & Kadri Altundag. (2014) Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer. Medical Oncology 31:2.
Crossref
Crossref
Grégory Verhoest, Thibault Dolley-Hitze, Florence Jouan, Marc-Antoine Belaud-Rotureau, Emmanuel Oger, Audrey Lavenu, Karim Bensalah, Yannick Arlot-Bonnemains, Nicolas Collet, Nathalie Rioux-Leclercq & Cécile Vigneau. (2014) Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma. BioMed Research International 2014, pages 1-9.
Crossref
Crossref
Caroline P. Le, Tara Karnezis, Marc G. Achen, Steven A. Stacker & Erica K. Sloan. (2013) Lymphovascular and neural regulation of metastasis: Shared tumour signalling pathways and novel therapeutic approaches. Best Practice & Research Clinical Anaesthesiology 27:4, pages 409-425.
Crossref
Crossref
Vikash P. Chauhan, John D. Martin, Hao Liu, Delphine A. Lacorre, Saloni R. Jain, Sergey V. Kozin, Triantafyllos Stylianopoulos, Ahmed S. Mousa, Xiaoxing Han, Pichet Adstamongkonkul, Zoran Popović, Peigen Huang, Moungi G. Bawendi, Yves Boucher & Rakesh K. Jain. (2013) Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nature Communications 4:1.
Crossref
Crossref
Stefan Nickels, Alina Vrieling, Petra Seibold, Judith Heinz, Nadia Obi, Dieter Flesch-Janys & Jenny Chang-Claude. (2013) Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort. PLoS ONE 8:9, pages e75088.
Crossref
Crossref
Cesar A. Santa-Maria & Vered Stearns. (2013) Statins and Breast Cancer: Future Directions in Chemoprevention. Current Breast Cancer Reports 5:3, pages 161-169.
Crossref
Crossref
Laura W Bowers, David A Cavazos, Ilane XF Maximo, Andrew J Brenner, Stephen D Hursting & Linda A deGraffenried. (2013) Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression. Breast Cancer Research 15:4.
Crossref
Crossref
Derick Okwan-Duodu, Jerome Landry, Xiao Z. Shen & Roberto Diaz. (2013) Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 305:3, pages R205-R215.
Crossref
Crossref
T M Brewer, H Masuda, D D Liu, Y Shen, P Liu, T Iwamoto, K Kai, C M Barnett, W A Woodward, J M Reuben, P Yang, G N Hortobagyi & N T Ueno. (2013) Statin use in primary inflammatory breast cancer: a cohort study. British Journal of Cancer 109:2, pages 318-324.
Crossref
Crossref
Gitte Vrelits SørensenPatricia A. GanzSteven W. ColeLars A. PedersenHenrik Toft SørensenDeirdre P. Cronin-FentonJens Peter GarnePeer M. ChristiansenTimothy L. LashThomas P. Ahern. (2013) Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study. Journal of Clinical Oncology 31:18, pages 2265-2272.
Crossref
Crossref
Michelle D. Holmes, Susan E. Hankinson, Diane Feskanich & Wendy Y. Chen. (2013) Beta blockers and angiotensin-converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use. Breast Cancer Research and Treatment 139:2, pages 507-513.
Crossref
Crossref
Sarah Nechuta, Wei Lu, Ying Zheng, Hui Cai, Ping-Ping Bao, Kai Gu, Wei Zheng & Xiao Ou Shu. (2013) Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast Cancer Research and Treatment 139:1, pages 227-235.
Crossref
Crossref
Thibault Dolley-Hitze, Grégory Verhoest, Florence Jouan, Patrick Le Pogamp, Yannick Arlot-Bonnemains, Emmanuel Oger, Marc-Antoine Belaud-Rotureau, Nathalie Rioux-Leclercq & Cécile Vigneau. (2013) Récepteurs de type 1 à l’angiotensine-2 (AT1R) et cancers. Néphrologie & Thérapeutique 9:2, pages 85-91.
Crossref
Crossref
Yousuke Nakai, Hiroyuki Isayama, Takashi Sasaki, Suguru Mizuno, Naoki Sasahira, Hirofumi Kogure, Kazumichi Kawakubo, Natsuyo Yamamoto, Kenji Hirano, Hideaki Ijichi, Keisuke Tateishi, Minoru Tada & Kazuhiko Koike. (2013) Clinical Outcomes of Chemotherapy for Diabetic and Nondiabetic Patients With Pancreatic Cancer. Pancreas 42:2, pages 202-208.
Crossref
Crossref
Øystein Kravdal. (2013) The poorer cancer survival among the unmarried in Norway: Is much explained by comorbidities?. Social Science & Medicine 81, pages 42-52.
Crossref
Crossref
N Alikhani, R D Ferguson, R Novosyadlyy, E J Gallagher, E J Scheinman, S Yakar & D LeRoith. (2012) Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Oncogene 32:8, pages 961-967.
Crossref
Crossref
Archana Gopalan, Weiping Yu, Bob G. Sanders & Kimberly Kline. (2013) Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. Cancer Letters 329:1, pages 9-16.
Crossref
Crossref
Gregory S. Calip, Denise M. Boudreau & Elizabeth T. Loggers. (2013) Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Research and Treatment 138:1, pages 225-233.
Crossref
Crossref
Oscar Zuñiga, Víctor H. Vázquez, Ana María Velázquez, Víctor H. Abrego, Sandra Díaz-Barriga Arceo, Patricia Ramírez, Roberto Díaz & Enrique Angeles. (2013) Molecular Docking of 4-Tert-buthyl-bis-(2,6-thiomorpholin-4-ylmethyl)-1-phenol (LQM319) on Fas Receptor (CD95). Journal of Cancer Therapy 04:01, pages 176-181.
Crossref
Crossref
Archana Gopalan, Weiping Yu, Bob G. Sanders & Kimberly Kline. (2013) Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol. Cancer Letters 328:2, pages 285-296.
Crossref
Crossref
Michelle D Holmes & Wendy Y Chen. (2012) Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Research 14:2.
Crossref
Crossref
Krishna Undela, Vallakatla Srikanth & Dipika Bansal. (2012) Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Research and Treatment 135:1, pages 261-269.
Crossref
Crossref
De-shen Wang, Zhi-qiang Wang, Le Zhang, Miao-zhen Qiu, Hui-yan Luo, Chao Ren, Dong-sheng Zhang, Feng-hua Wang, Yu-hong Li & Rui-hua Xu. (2012) Are Risk Factors Associated with Outcomes in Pancreatic Cancer?. PLoS ONE 7:7, pages e41984.
Crossref
Crossref
Christophe Ginestier, Florence Monville, Julien Wicinski, Olivier Cabaud, Nathalie Cervera, Emmanuelle Josselin, Pascal Finetti, Arnaud Guille, Gaelle Larderet, Patrice Viens, Said Sebti, François Bertucci, Daniel Birnbaum & Emmanuelle Charafe-Jauffret. (2012) Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target. Stem Cells 30:7, pages 1327-1337.
Crossref
Crossref
Sylvie Rodrigues-Ferreira, Mohamed Abdelkarim, Patricia Dillenburg-Pilla, Anny-Claude Luissint, Anne di-Tommaso, Frédérique Deshayes, Carmen Lucia S. Pontes, Angie Molina, Nicolas Cagnard, Franck Letourneur, Marina Morel, Rosana I. Reis, Dulce E. Casarini, Benoit Terris, Pierre-Olivier Couraud, Claudio M. Costa-Neto, Mélanie Di Benedetto & Clara Nahmias. (2012) Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis. PLoS ONE 7:4, pages e35667.
Crossref
Crossref
Úna C. Mc Menamin, Liam J. Murray, Marie M. Cantwell & Carmel M. Hughes. (2011) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. Cancer Causes & Control 23:2, pages 221-230.
Crossref
Crossref